EUVIMEDEUVIMED entdecken
Systematische ÜbersichtMetaanalyse

Epidemiology of Vancomycin in Combination With Piperacillin/Tazobactam-Associated Acute Kidney Injury in Children: A Systematic Review and Meta-analysis

Miao Zhang iD, Liang Huang, Yu Zhu, Linan Zeng, Zhi-Jun Jia, Guo Cheng, Hailong Li, Lingli Zhang

Annals of Pharmacotherapy · 2024

DOI: 10.1177/10600280231220379 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift Annals of Pharmacotherapy, 2024. Verfasst von Miao Zhang und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, West China Second University Hospital, Sichuan University, Chengdu, China. Hauptthemen laut MEDLINE: Vancomycin, Acute Kidney Injury, Piperacillin, Tazobactam Drug Combination, Anti-Bacterial Agents. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 58 Literaturangaben. Gefördert von: National Natural Science Foundation for Young Scholars of China, national outstanding youth science fund project of national natural science foundation of china.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Several studies have shown that vancomycin combined with piperacillin/tazobactam (VPT) increased the risk of acute kidney injury (AKI) compared with other antibiotics in children. However, the epidemiology of VPT-associated AKI in children is unknown.

Objective

To evaluate the incidence and risk factors of VPT-associated AKI in children. Data sources: Literature databases of PubMed, Embase, Cochrane Library, China National Knowledge Infrastructure (CNKI), VIP Database, WanFang Database, and China Biology Medicine Disc were searched from inception to November 2023. References of included studies were also manually checked. Study selection and data extraction: Two independent reviewers selected studies, extracted data, and quality assessment. Meta-analyses were performed to quantify the incidence and risk factors of VPT-associated AKI in children. Data synthesis: Sixteen cohort studies were identified. Overall, the incidence of VPT-associated AKI in children was 24.3% (95% CI: 17.9%-30.6%). The incidence of VPT-associated AKI in critically ill children (26.6%) was higher than that in noncritically ill children (10.9%). Moreover, higher serum vancomycin trough concentration (>15 mg/L), use of vasopressors, combination of nephrotoxins and intensive care unit admission were risk factors for VPT-associated AKI in children ( P < 0.05). Relevance to patient care and clinical practice: Identifying high-risk groups and determining safer treatments is critical to reducing the incidence of VPT-associated AKI in children.

Conclusions

The incidence of VPT-associated AKI in children is high, especially in critically ill children. Medication regimens should be personalized based on the presence of individual risk factors. Moreover, renal function was regularly assessed throughout treatment with VPT.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

VancomycinAcute Kidney InjuryPiperacillin, Tazobactam Drug CombinationAnti-Bacterial AgentsHumansChildIncidenceRisk FactorsDrug Therapy, CombinationCritical Illness

Stichwörter der Autor:innen

acute kidney injuryincidencepiperacillin/tazobactamrisk factorvancomycin

Substanzen

VancomycinPiperacillin, Tazobactam Drug CombinationAnti-Bacterial Agents

Autor:innen und Institutionen

  • Department of Pharmacy, West China Second University Hospital, Sichuan University, Chengdu, China.
  • Evidence-Based Pharmacy Center, West China Second University Hospital, Sichuan University, Chengdu, China.
  • NMPA Key Laboratory for Technical Research on Drug Products In Vitro and In Vivo Correlation, Chengdu, China.
  • Key Laboratory of Birth Defects and Related Diseases of Women and Children, Sichuan University, Ministry of Education, Chengdu, China.
  • West China School of Pharmacy, Sichuan University, Chengdu, China.
  • Department of Pediatrics, West China Second University Hospital, Sichuan University, Chengdu, China.

ORCID-Profile: Miao Zhang

Förderung

  • National Natural Science Foundation for Young Scholars of China
  • national outstanding youth science fund project of national natural science foundation of china

Zitieren

APA

Zhang, M., Huang, L., Zhu, Y., Zeng, L., Jia, Z. J., Cheng, G., Li, H., & Zhang, L. (2024). Epidemiology of Vancomycin in Combination With Piperacillin/Tazobactam-Associated Acute Kidney Injury in Children: A Systematic Review and Meta-analysis. Annals of Pharmacotherapy. https://doi.org/10.1177/10600280231220379

Vancouver

Zhang M, Huang L, Zhu Y, Zeng L, Jia ZJ, Cheng G, et al. Epidemiology of Vancomycin in Combination With Piperacillin/Tazobactam-Associated Acute Kidney Injury in Children: A Systematic Review and Meta-analysis. Annals of Pharmacotherapy. 2024. doi:10.1177/10600280231220379

BibTeX
@article{Zhang2024,
  author = {Zhang, Miao and Huang, Liang and Zhu, Yu and Zeng, Linan and Jia, Zhi-Jun and Cheng, Guo and Li, Hailong and Zhang, Lingli},
  title = {Epidemiology of Vancomycin in Combination With Piperacillin/Tazobactam-Associated Acute Kidney Injury in Children: A Systematic Review and Meta-analysis},
  journal = {Annals of Pharmacotherapy},
  year = {2024},
  doi = {10.1177/10600280231220379}
}
Kostenlos starten →